tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market
Advertisement

Actuate Therapeutics, Inc. (ACTU) Similar Stocks

Compare
21 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$8.24
$180.90M
1.10%
3 Buy
0 Hold
0 Sell
Strong Buy
Agenus
$4.33
$136.70M
-12.53%
2 Buy
0 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$2.94
$163.40M
12.42
-45.56%
4 Buy
0 Hold
0 Sell
Strong Buy
Nkarta
$2.26
$151.28M
-58.38%
6 Buy
1 Hold
0 Sell
Strong Buy
C4 Therapeutics
$2.72
$190.03M
-49.63%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kyverna Therapeutics, Inc.
$3.94
$170.39M
-46.32%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
8.24
-0.03
-0.36%
AGEN
Agenus
4.33
-0.80
-15.59%
BDTX
Black Diamond Therapeutics
2.94
-2.72
-48.06%
NKTX
Nkarta
2.26
-3.65
-61.76%
CCCC
C4 Therapeutics
2.72
-3.01
-52.53%
KYTX
Kyverna Therapeutics, Inc.
3.94
-3.44
-46.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis